1. Mizel, S. B. 1982. Interleukin 1 and T cell activation.Immunol. Rev. 63:51?71.
2. Rosenwasser, L. J. 1984. Interleukin 1: An overview.Proc. IUPHAR 9th Cong. Pharmacol. 3:301?309.
3. Dinarello, C. A., J. G. Cannon, J. W. Mier, H. A. Bernheim, G. LoPreste, D. L. Lynn, R. N. Love, A. C. Webb, P. E. Auron, R. C. Reubon, A. Rich, S. M. Wolff, andS. D. Putney. 1986. Multiple biological activities of human recombinant interleukin 1.J. Clin. Invest. 77:1734?1739.
4. Luger, T. A., J. A. Charon, M. Colot, M. Micksche, andJ. J. Oppenheim. 1983. Chemotactic properties of partially purified human epidermal cell derived thymocyte-activation factor (ETAF) for polymorphonuclear and mononuclear cells.J. Immunol. 131:816?820.
5. Sauder, D. N., N. L. Mounessa, S. I. Katz, C. A. Dinarello, andJ. I. Gallin. 1984. Chemotactic cytokines: The role of leukocyte pyrogen and epidermal cell thymocyte-activating factor in neutrophil chemotaxis.J. Immunol. 132:828?832.